Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT01612260
Eligibility Criteria:
Inclusion Criteria:
* Patients with cardiac function NYHA II\~III, Left ventricular ejection fraction (LVEF) 35%\~50% tested by Modified Simpson, has a stable hemodynamics and no need to deliver treatment through vein
* To be treated by standard treatment of heart failure at least 3 months with a stable dosage already
* Ventricular premature beats: 720-10000 beats/24 hours
* Heart failure caused by ischemic heart disease, or dilated cardiomyopathy
Exclusion Criteria:
* Subject to be expected to alive no more than 6 months
* Subject suffered from acute coronary syndrome in last three months (Acute myocardial infarction of ST segment elevation and non ST segment elevation, unstable angina
* To be complicated with persistent atrial fibrillation, atrioventricular conduction block (II degree of Type II or III degree), or acute myocarditis
* To be complicated with ventricular fibrillation, torsion type ventricular heartbeat rate, sustained ventricular tachycardia, or non sustained ventricular tachycardia with rapid ventricular rate and hemodynamic disorders
* Sinus heart rate less than 45 beats/minutes and needs to receive the pacemaker or has received pacemaker, or with abnormal sinus node function
* The hypertension, diabetes difficult to be controlled
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01612260
Study Brief:
Protocol Section:
NCT01612260